Cargando…
Dysregulation of SOX17/NRF2 axis confers chemoradiotherapy resistance and emerges as a novel therapeutic target in esophageal squamous cell carcinoma
BACKGROUND: Esophageal squamous cell carcinoma (ESCC) is the sixth leading cause of cancer-associated death worldwide with a dismal overall 5-year survival rate of less than 20%. The standard first-line therapy for advanced ESCC is concomitant chemo-radiation therapy (CCRT); however, patients usuall...
Autores principales: | Hsieh, Chih-Hsiung, Kuan, Wen-Hui, Chang, Wei-Lun, Kuo, I-Ying, Liu, Hsun, Shieh, Dar-Bin, Liu, Hsuan, Tan, Bertrand, Wang, Yi-Ching |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618214/ https://www.ncbi.nlm.nih.gov/pubmed/36310172 http://dx.doi.org/10.1186/s12929-022-00873-4 |
Ejemplares similares
-
SOX17 overexpression sensitizes chemoradiation response in esophageal cancer by transcriptional down-regulation of DNA repair and damage response genes
por: Kuo, I-Ying, et al.
Publicado: (2019) -
An innovative NRF2 nano-modulator induces lung cancer ferroptosis and elicits an immunostimulatory tumor microenvironment
por: Hsieh, Chih-Hsiung, et al.
Publicado: (2021) -
A SOX17-PDGFB signaling axis regulates aortic root development
por: Lu, Pengfei, et al.
Publicado: (2022) -
Nrf2 and Keap1 abnormalities in esophageal squamous cell carcinoma and association with the effect of chemoradiotherapy
por: Zhang, Jingze, et al.
Publicado: (2018) -
The SOX4/miR-17-92/RB1 Axis Promotes Prostate Cancer Progression
por: Liu, Hui, et al.
Publicado: (2019)